Related Experiment Video

Updated: Jun 3, 2026

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
05:51

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

Published on: May 6, 2014

The interplay of inflammation and cardiovascular disease in systemic lupus erythematosus

J Michelle Kahlenberg1, Mariana J Kaplan

  • 1Department of Internal Medicine, University of Michigan,nn Arbor, MI 48109-5680, USA.

Arthritis Research & Therapy
|March 5, 2011
PubMed

Insights

Systemic lupus erythematosus significantly raises cardiovascular disease risk due to inflammation and immune factors. Understanding these mechanisms, including cytokines like type I interferons, is key to preventing accelerated atherosclerosis in lupus patients.

Area of Science:

  • Cardiovascular Science
  • Immunology
  • Rheumatology

Background:

  • Systemic lupus erythematosus (SLE) patients face a substantially elevated risk, up to 50-fold, of atherosclerotic cardiovascular disease (ASCVD).
  • Vascular damage in SLE arises from complex interactions between lupus-specific inflammation and conventional cardiovascular risk factors, causing endothelial dysfunction.
  • Accelerated atherosclerosis in SLE is a significant clinical concern, contributing to morbidity and mortality.

Purpose of the Study:

  • To review the role of immune dysregulation in the pathogenesis of premature vascular damage in SLE.
  • To examine the specific contribution of lupus-associated inflammatory factors, including cytokines, to accelerated atherosclerosis.
  • To discuss potential therapeutic targets for mitigating cardiovascular risk in SLE patients.

Main Methods:

  • Literature review focusing on immunological and inflammatory pathways in SLE-related cardiovascular disease.
  • Analysis of studies investigating the impact of cytokines, particularly type I interferons, on endothelial function and atherosclerosis.
  • Synthesis of current understanding regarding the interplay between SLE-specific factors and traditional cardiovascular risk.

Main Results:

  • Immune dysregulation and lupus-specific inflammatory mediators are implicated in the pathogenesis of early-onset atherosclerosis in SLE.
  • Type I interferons and other cytokines may play a critical role in promoting endothelial damage and vascular inflammation.
  • The combination of autoimmune processes and traditional risk factors exacerbates cardiovascular risk in SLE.

Conclusions:

  • Immune dysregulation is a key driver of accelerated atherosclerosis in systemic lupus erythematosus.
  • Targeting lupus-specific inflammatory pathways, such as those involving type I interferons, offers potential therapeutic strategies.
  • Further research into these mechanisms is crucial for developing effective interventions to reduce cardiovascular events in SLE patients.

More Related Videos

Flow Cytometry Analysis of Immune Cells Within Murine Aortas15:15

Flow Cytometry Analysis of Immune Cells Within Murine Aortas

Published on: July 1, 2011

Related Concept Videos

Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Acute Inflammation III: Local and Systemic Effects01:25

Acute Inflammation III: Local and Systemic Effects

Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Inflammatory Response I: Vascular and Cellular01:30

Inflammatory Response I: Vascular and Cellular

The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...